Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia.
Journal: Schizophrenia research
Published: December 06, 2023
Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individuals.
Journal: Journal of sleep research
Published: November 10, 2022
Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 22, 2022
A natural history study to track brain and spinal cord changes in individuals with Friedreich's ataxia: TRACK-FA study protocol.
Journal: PloS one
Published: January 09, 2022
Advancing combination therapy for Alzheimer's disease.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: July 09, 2020
Showing 1-6 of 6
Last Updated: 09/26/2026